250725 BICHEDAM Participates in AFPRO 2025, Agri-Food Excellence FoodTech Startup Expo

‘G-Pyeonan Liquid’ Draws Buyer Attention with Blood Circulation Improvement and Leg Muscle Cramp Relief Benefits

[BIO TIMES] BICHEDAM, a natural product-based new drug development company, announced that it participated in the “2025 Agro-Food Tech Startup Expo (AFPRO 2025)” held at COEX, Seoul, from July 16 (Wed) to 18 (Fri), with support from the Ministry of Agriculture, Food and Rural Affairs and the Korea Agricultural Technology Promotion Agency.

BICHEDAM has been selected for the “Green Unicorn (G-Corn)” program of the “2025 Agro-Food Technology Startup Accelerator Support Project,” hosted by the Ministry of Agriculture, Food and Rural Affairs, organized by the Korea Agricultural Technology Promotion Agency, and operated by Y&Archer, strengthening its foundation for domestic and international market entry and investment attraction.

At the exhibition, BICHEDAM showcased its flagship product, “G-Pyeonan Liquid.” This premium health functional product, based on herbal ingredients, helps improve blood circulation and relieve leg muscle cramps, attracting significant interest from buyers at the event.

The accelerator Y&Archer, the event operator, also actively supported tangible outcomes for startups by arranging one-on-one meetings with investors and buyers.

Ho-bin Moon, CEO of BICHEDAM, said, “This event provided an excellent opportunity to successfully showcase BICHEDAM’s technology and vision. We aim to lead innovation in the agro-food healthcare sector not only through the commercialization of functional products but also through new drug development based on BCD101.”

BICHEDAM is also accelerating the development of its ROCK inhibitor-based degenerative disease drug candidate, “BCD101.” On July 4, the company received approval for the clinical trial plan (IND) for BCD101 from the Ministry of Food and Drug Safety, and clinical trials are set to begin in September at Chungbuk National University Hospital, marking an important step forward in new drug development.
Source : https://www.biotimes.co.kr/news/articleView.html?idxno=22904